全球狂犬病診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

狂犬病診斷市場預計將從 2025 年的 27 億美元成長到 2034 年的 40 億美元，2026 年至 2034 年的複合年成長率為 4.44%。

由於狂犬病在發展中地區持續蔓延，全球狂犬病診斷市場正穩定成長。各國主導加強根除狂犬病，推動了對診斷檢測的需求。早期準確檢測對於有效控制和預防疾病至關重要。獸醫基礎設施的擴建促進了市場成長。疫苗接種和檢測宣傳活動的加強提高了篩檢率。分子診斷技術的進步提高了檢測的準確性。全球為實現狂犬病零死亡所做的努力也支撐了市場的未來發展前景。

另一個重要的促進因素是快速診斷試劑盒在農村和偏遠地區的廣泛應用。就地檢驗解決方案提高了檢測的可及性，並縮短了檢測結果的獲取時間。世界衛生組織正在資助地方性流行國家的狂犬病監測計畫。某些地區流浪動物數量的增加提高了檢測需求。研究機構正致力於開發經濟高效的攜帶式檢測設備。公私合營正在加強分銷網路。 PCR和免疫檢測技術的進步將在預測期內加速成長。

此外，全球獸醫診斷和檢測能力的提升正在影響市場。伴侶動物醫療費用支出的增加推動了對常規體檢的需求。低溫運輸物流的改善促進了診斷劑的配送。監管機構正致力於推廣標準化診斷通訊協定，以確保其可靠性。政府與非政府組織之間合作的加強正在改善疾病監測系統。生技公司正投資開發創新檢測方法。從長遠來看，綜合監測系統和數位化報告平台將進一步提升狂犬病診斷市場的前景。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球狂犬病診斷市場：依診斷方法分類

• 市場分析、洞察與預測
• 螢光測定法（FAT）
• 免疫組織化學檢查
• 擴增方法
• 組織學檢查
• 血清學檢測

第5章 全球狂犬病診斷市場：依技術與方法分類

• 市場分析、洞察與預測
• 酵素連結免疫吸附試驗/免疫組織化學
• 層析法技術
• PCR
• 其他

第6章 全球狂犬病診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bio-Rad Laboratories Inc
  • Aviva Systems Biology Corporation
  • Merck KGaA
  • Demeditec Diagnostics GmbH
  • Creative Diagnostics
  • Norgen Biotek Corp
  • Abbexa Ltd
  • Express Biotech International Inc
  • BioNote Inc
  • MyBioSource.Com

The Rabies Diagnostics Market size is expected to reach USD 4.00 Billion in 2034 from USD 2.70 Billion (2025) growing at a CAGR of 4.44% during 2026-2034.

The Global Rabies Diagnostics Market is growing steadily due to the continued prevalence of rabies in developing regions. Increasing government initiatives aimed at rabies elimination are driving diagnostic testing demand. Early and accurate detection is critical for effective disease management and prevention. The expansion of veterinary healthcare infrastructure is contributing to market growth. Rising awareness campaigns regarding vaccination and testing are increasing screening rates. Technological advancements in molecular diagnostic techniques are improving accuracy. Future prospects are supported by global efforts to achieve zero rabies deaths.

Another significant driver is the increasing adoption of rapid diagnostic kits in rural and remote areas. Point-of-care testing solutions are enhancing accessibility and reducing turnaround time. International health organizations are funding rabies surveillance programs in endemic countries. The growing population of stray animals in certain regions is increasing testing requirements. Research institutions are focusing on developing cost-effective and portable testing devices. Public-private partnerships are strengthening distribution networks. Over the forecast period, advancements in PCR-based and immunoassay technologies will accelerate growth.

The market is also influenced by expanding veterinary diagnostics and laboratory capabilities worldwide. Companion animal healthcare expenditure is rising, boosting routine testing demand. Improved cold chain logistics are supporting distribution of diagnostic reagents. Regulatory agencies are promoting standardized diagnostic protocols to ensure reliability. Increasing collaboration between governments and NGOs is improving disease monitoring systems. Biotechnology companies are investing in innovative assay development. In the long term, integrated surveillance systems and digital reporting platforms will further enhance the rabies diagnostics market outlook.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Diagnostic Method

• Fluorescent Antibody Test (FAT)
• Immunohistochemical Test
• Amplification Methods
• Histologic Examination
• Serology Tests

By Technology Method

• ELISA/Immunohistochemistry
• Chromatography Techniques
• PCR
• Others

COMPANIES PROFILED

• BioRad Laboratories Inc, Aviva Systems Biology Corporation, Merck KGaA, Demeditec Diagnostics GmbH, Creative Diagnostics, Norgen Biotek Corp, Abbexa Ltd, Express Biotech International Inc, BioNote Inc, MyBioSourcecom
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RABIES DIAGNOSTICS MARKET: BY DIAGNOSTIC METHOD 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Diagnostic Method
• 4.2. Fluorescent Antibody Test (FAT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunohistochemical Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Amplification Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Histologic Examination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Serology Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RABIES DIAGNOSTICS MARKET: BY TECHNOLOGY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology Method
• 5.2. ELISA/Immunohistochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chromatography Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RABIES DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Diagnostic Method
  • 6.2.2 By Technology Method
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Diagnostic Method
  • 6.3.2 By Technology Method
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Diagnostic Method
  • 6.4.2 By Technology Method
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Diagnostic Method
  • 6.5.2 By Technology Method
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Diagnostic Method
  • 6.6.2 By Technology Method
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL RABIES DIAGNOSTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Bio-Rad Laboratories Inc
  • 8.2.2 Aviva Systems Biology Corporation
  • 8.2.3 Merck KGaA
  • 8.2.4 Demeditec Diagnostics GmbH
  • 8.2.5 Creative Diagnostics
  • 8.2.6 Norgen Biotek Corp
  • 8.2.7 Abbexa Ltd
  • 8.2.8 Express Biotech International Inc
  • 8.2.9 BioNote Inc
  • 8.2.10 MyBioSource.Com